[New clinical guidelines for COPD - a paradigm shift: A review].

Area of Science:

• Pulmonology
• Epidemiology
• Pharmacology

Background:

• Chronic obstructive pulmonary disease (COPD) is a leading global cause of morbidity, disability, and mortality.
• Recent advancements have reshaped the understanding and management of COPD.
• Evolving diagnostic and classification methods are crucial for patient care.

Purpose of the Study:

• To review recent advancements in COPD epidemiology, diagnosis, and management.
• To highlight the impact of new clinical trial data on therapeutic approaches.
• To discuss the integration of pharmacologic and non-pharmacologic interventions.

Main Methods:

• Review of recent major clinical trials in COPD.
• Analysis of updated guidelines for COPD diagnosis and classification.
• Evaluation of evidence for triple fixed-combination therapies.
• Assessment of non-medication strategies including smoking cessation and rehabilitation.

Main Results:

• Triple fixed combinations (inhaled glucocorticosteroids, long-acting beta-agonists, long-acting anticholinergic drugs) show high efficacy.
• Non-medication methods like smoking cessation, physical activity, and respiratory rehabilitation are vital.
• Modern approaches to respiratory failure and antibiotic therapy are essential.

Conclusions:

• Recent updates represent a novel paradigm in COPD diagnosis and management.
• Integrated approaches combining pharmacotherapy and non-pharmacologic interventions improve clinical practice.
• These advancements significantly impact real-world patient care and outcomes.